Clever Leaves Holdings Inc
OTC:CLVR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0001
0.0275
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Gross Margin
Clever Leaves Holdings Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CO |
|
Clever Leaves Holdings Inc
OTC:CLVR
|
518.3 USD |
38%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
946.5B USD |
83%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
56%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
484B USD |
68%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
252.4B CHF |
74%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.5B GBP |
82%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
204.5B CHF |
76%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
244.6B USD |
79%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
82%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
202.5B USD |
68%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
147.3B USD |
75%
|
Clever Leaves Holdings Inc
Glance View
Clever Leaves Holdings Inc. is a leading player in the global cannabis industry, with a mission to provide high-quality, sustainable, and compliant cannabinoid products. Founded in 2018 and headquartered in New York, this vertically integrated company has established a robust operational presence in key markets, including Colombia, the United States, and Europe. Clever Leaves differentiates itself with a focus on international cultivation and distribution, leveraging Colombia's ideal climate for cannabis production, resulting in cost-effective and high-quality products. This strategic positioning allows the company to cater to a diverse customer base, from pharmaceutical companies to consumer brands, as it navigates the emerging global cannabinoid landscape. As an investor, you’ll find that Clever Leaves embodies the principles of responsible growth and innovation through its unwavering commitment to compliance and quality. With multiple certifications enabling it to trade in international markets, the company is well-prepared to capitalize on the evolving regulations surrounding cannabis. Their expansive research and development initiatives, along with solid supply chain management, aim to unlock new product opportunities, positioning Clever Leaves for potential long-term success in the burgeoning cannabinoid sector. As the global market continues to mature, Clever Leaves is poised to take advantage of expanding consumer demand for cannabis-derived products, making it an intriguing investment opportunity for those looking to enter this dynamic and rapidly growing industry.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Clever Leaves Holdings Inc's most recent financial statements, the company has Gross Margin of 37.6%.